The Wisconsin Registry for Alzheimer's Prevention is a longitudinal observational cohort
study enriched with persons with a parental history (PH) of probable Alzheimer's disease (AD) …

Blood biomarkers indicative of Alzheimer’s disease (AD) pathology are altered in both
preclinical and symptomatic stages of the disease. Distinctive biomarkers may be optimal for the …

Importance Converging evidence suggests that Alzheimer disease (AD) involves insulin
signaling impairment. Patients with AD and individuals at risk for AD show reduced glucose …

Importance Alzheimer disease (AD) pathology starts with a prolonged phase of β-amyloid (Aβ)
accumulation without symptoms. The duration of this phase differs greatly among …

Background Insulin resistance (IR) increases Alzheimer's disease (AD) risk. IR is related to
greater amyloid burden post-mortem and increased deposition within areas affected by early …

OBJECTIVE Insulin resistance dysregulates glucose uptake and other functions in brain
areas affected by Alzheimer disease. Insulin resistance may play a role in Alzheimer disease …

Background Metabolic syndrome (MetS)—a cluster of cardiovascular risk factors—is linked
with cognitive decline and dementia. However, the brain changes underlying this link are …

Introduction This study examines the utility of a multipanel of cerebrospinal fluid (CSF)
biomarkers complementing Alzheimer's disease (AD) biomarkers in a clinical research sample. …

White matter hyperintensities (WMH) of presumed vascular origin, as seen on T2-weighted
fluid attenuated inversion recovery magnetic resonance imaging, are known to increase with …

This study investigated differences in retrospective cognitive trajectories between amyloid
and tau PET biomarker stratified groups in initially cognitively unimpaired participants …